Skip to main content
Article
Licensed
Unlicensed Requires Authentication

Adverse Events During Growth Hormone Therapy

  • and
Published/Copyright: October 1, 1995

Published Online: 1995-10

©2011 by Walter de Gruyter GmbH & Co.

Articles in the same Issue

  1. TABLE OF CONTENTS
  2. Does Recombinant Human Insulin-Like Growth Factor I Have a Role in the Treatment of Type I (Insulin Dependent) Diabetes During Puberty?
  3. Adverse Events During Growth Hormone Therapy
  4. A Possible New Syndrome of Familial Euthyroid Dysproteinemia Associated with Elevated Thyroxine and Triiodothyronine
  5. Continuous Infusion of Vasopressin in Comatose Children with Neurogenic Diabetes Insipidus
  6. Primary Hypothyroidism and Concomitant Bilateral Ovarian Masses
  7. Sonographic Appearance of Ovaries and Gonadotropin Secretions as Prognostic Tools of Spontaneous Puberty in Girls with Turner's Syndrome
  8. Does Primary Salt Wasting Occur in 11-Beta-Hydroxylase Deficiency?
  9. Assessment of Hypothalamic-Pituitary-Adrenocortical Axis Function in Dexamethasone Treated Very Low Birth Weight Infants by a Single Dose Metyrapone Test and Gas Chromatographic Mass Spectrometric Determination of Urinary Steroids
  10. Transient Central Precocious Puberty in Non-Classic 21-Hydroxylase Deficiency
  11. Precocious Puberty in Three Boys with Sanfilippo A (Mucopolysaccharidosis III A)
  12. Pseudo-Precocious Puberty in a Male Patient and the Melatonin-Testosterone Relationship
  13. Neurogenic Diabetes Insipidus in a Child with Fatal Coxsackie Virus B1 Encephalitis
  14. Maroteaux-Lamy Syndrome Associated with Growth Hormone Deficiency
  15. An Estimate of the Upper Limit for the Rate of Adverse Cardiac Effects in Children Treated with Growth Hormone
  16. Small Peptides as Potent Releasers of Growth Hormone
  17. BOOK REVIEWS. INDEX
Downloaded on 20.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/JPEM.1995.8.4.243/html
Scroll to top button